| Financial Year |
March 31 2023 |
| Monetary Funds |
437,615,919.58 |
| Held-for-trading Financial Assets |
40,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
185,439,119.64 |
| Advances to Suppliers |
5,760,454.89 |
| Other Receivables |
1,305,770.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
458,031,512.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,761,266.34 |
| Total Current Assets |
1,175,211,079.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,985.56 |
| Fixed Assetes |
845,721,560.88 |
| Under-construction Projects |
208,638,512.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,422,749.86 |
| R&D expenses |
367,200.00 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,760,738.49 |
| Deferred Income Tax Assets |
11,311,811.38 |
| Other Non-Current Assets |
177,551,069.01 |
| Sub-Total of Non-Current Assets |
1,335,112,267.93 |
| Total Assets |
2,510,323,347.67 |
| Short-Term Loans |
135,058,666.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,417,000.00 |
| Accounts Payable |
271,652,429.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,748,691.88 |
| Taxes Payable |
10,616,108.72 |
| Interest Payable |
-- |
| Dividend Payable |
437,500.00 |
| Other payables |
4,536,981.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,622,906.60 |
| Other Current Liabilities |
165,416.69 |
| Sub-Total of Current Liabilities |
562,449,924.48 |
| Long-term Loans |
32,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
836,909.11 |
| Deferred Income Tax Liabilities |
264,615.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
84,864,150.76 |
| Total Liabilities |
647,314,075.24 |
| Paid-In Capital(Or Share Stock) |
113,600,000.00 |
| Capital Surplus |
1,128,661,441.28 |
| Surplus Reserve |
38,251,451.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
582,979,073.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,863,009,272.43 |
| Owner's Equity（Stockholder's Equity） |
1,863,009,272.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,510,323,347.67 |
